These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7562785)

  • 1. Economic analysis alongside clinical trials: problems and potential.
    Drummond M
    J Rheumatol; 1995 Jul; 22(7):1403-7. PubMed ID: 7562785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis alongside clinical trials. Revisiting the methodological issues.
    Drummond MF; Davies L
    Int J Technol Assess Health Care; 1991; 7(4):561-73. PubMed ID: 1778701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness as an outcome in randomized clinical trials.
    Hlatky MA; Owens DK; Sanders GD
    Clin Trials; 2006; 3(6):543-51. PubMed ID: 17170039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An illustration of the modelling of cost and efficacy data from a clinical trial.
    Hahn S; Whitehead A
    Stat Med; 2003 Mar; 22(6):1009-24. PubMed ID: 12627415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analyses alongside randomised clinical trials.
    Gray AM
    Clin Trials; 2006; 3(6):538-42. PubMed ID: 17170038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of cost effectiveness in technology evaluation.
    Valk PE
    Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining quality health care with outcomes assessment while achieving economic value.
    Shaw LJ; Miller DD
    Top Health Inf Manage; 2000 Feb; 20(3):44-54. PubMed ID: 10747434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analysis alongside clinical trials: practical considerations. The Economics Workgroup.
    Drummond M; O'Brien B
    J Rheumatol; 1995 Jul; 22(7):1418-9. PubMed ID: 7562789
    [No Abstract]   [Full Text] [Related]  

  • 10. The application of economic evaluation methods in the chronic pain medicine literature.
    Vetter TR
    Anesth Analg; 2007 Jul; 105(1):114-8. PubMed ID: 17578966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the validity of economic evaluations alongside controlled trials.
    Dixon S; Deverill M; Gannon M; Brazier J; Haggard M
    J Health Serv Res Policy; 1999 Jul; 4(3):161-3. PubMed ID: 10538881
    [No Abstract]   [Full Text] [Related]  

  • 13. Practical applications of usability theory to electronic data collection for clinical trials.
    Schmier JK; Kane DW; Halpern MT
    Contemp Clin Trials; 2005 Jun; 26(3):376-85. PubMed ID: 15911471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conceptual issues in the analysis of cost data within cluster randomized trials.
    Flynn T; Peters T
    J Health Serv Res Policy; 2005 Apr; 10(2):97-102. PubMed ID: 15831192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
    Richardson G; Manca A
    Health Econ; 2004 Dec; 13(12):1203-10. PubMed ID: 15386669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing health economic outcome in Alzheimer's disease clinical trials.
    Jonsson L
    J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic analyses of clinical trials in cancer: are they helpful to policy makers?
    Bennett CL; Armitage JL; LeSage S; Gulati SC; Armitage JO; Gorin NC
    Stem Cells; 1994 Jul; 12(4):424-9. PubMed ID: 7951008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Integration of economic criteria in the recommendations for clinical practice in cancerology].
    Fervers B; Späth HM; Philip T; Carrère MO
    Bull Cancer; 1998 Mar; 85(3):272-80. PubMed ID: 9752319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance.
    Donaldson C; Hundley V; McIntosh E
    Health Econ; 1996; 5(3):267-9. PubMed ID: 8817300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.